A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 25, Issue 13, 1998, Pages 2055-2060

  Mizumatsu, S ^a   Matsumoto, K ^a   Maeda, Y ^a   Tamiya, T ^a   Furuta, T ^a   Ohmoto, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; CARBOPLATIN; ETOPOSIDE; NITROSOUREA DERIVATIVE; RANIMUSTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; NITROSOUREA COMPOUNDS; PROGNOSIS; SURVIVAL RATE;

EID: 0032215478     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)